Idioma:

Prostate Cancer, Version 3.2024

Schaeffer, Edward M ; Srinivas, Sandy ; Adra, Nabil ; An, Yi ; Bitting, Rhonda ; Chapin, Brian ; Cheng, Heather H ; D'Amico, Anthony Victor ; Desai, Neil ; Dorff, Tanya ; Eastham, James A ; Farrington, Thomas A ; Gao, Xin ; Gupta, Shilpa ; Guzzo, Thomas ; Ippolito, Joseph E ; Karnes, R Jeffrey ; Kuettel, Michael R ; Lang, Joshua M ; Lotan, Tamara ; McKay, Rana R ; Morgan, Todd ; Pow-Sang, Julio M ; Reiter, Robert ; Roach, Mack ; Robin, Tyler ; Rosenfeld, Stan ; Shabsigh, Ahmad ; Spratt, Daniel ; Szmulewitz, Russell ; Teply, Benjamin A ; Tward, Jonathan ; Valicenti, Richard ; Wong, Jessica Karen ; Snedeker, Jenna ; Freedman-Cass, Deborah A

Journal of the National Comprehensive Cancer Network, 2024-04, Vol.22 (3), p.140 [Periódico revisado por pares]

Sem texto completo

Citações Citado por

Título:
Prostate Cancer, Version 3.2024
Autor: Schaeffer, Edward M ; Srinivas, Sandy ; Adra, Nabil ; An, Yi ; Bitting, Rhonda ; Chapin, Brian ; Cheng, Heather H ; D'Amico, Anthony Victor ; Desai, Neil ; Dorff, Tanya ; Eastham, James A ; Farrington, Thomas A ; Gao, Xin ; Gupta, Shilpa ; Guzzo, Thomas ; Ippolito, Joseph E ; Karnes, R Jeffrey ; Kuettel, Michael R ; Lang, Joshua M ; Lotan, Tamara ; McKay, Rana R ; Morgan, Todd ; Pow-Sang, Julio M ; Reiter, Robert ; Roach, Mack ; Robin, Tyler ; Rosenfeld, Stan ; Shabsigh, Ahmad ; Spratt, Daniel ; Szmulewitz, Russell ; Teply, Benjamin A ; Tward, Jonathan ; Valicenti, Richard ; Wong, Jessica Karen ; Snedeker, Jenna ; Freedman-Cass, Deborah A
Assuntos: Humans ; Male ; Neoplasms, Second Primary ; Prostatic Neoplasms - diagnosis ; Prostatic Neoplasms - therapy ; Risk Assessment
É parte de: Journal of the National Comprehensive Cancer Network, 2024-04, Vol.22 (3), p.140
Descrição: The NCCN Guidelines for Prostate Cancer include recommendations for staging and risk assessment after a prostate cancer diagnosis and for the care of patients with localized, regional, recurrent, and metastatic disease. These NCCN Guidelines Insights summarize the panel's discussions for the 2024 update to the guidelines with regard to initial risk stratification, initial management of very-low-risk disease, and the treatment of nonmetastatic recurrence.
Editor: United States
Idioma: Inglês

Links

Voltar para lista de resultados

Anterior Resultado 5 Avançar Ir para próxima página